A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005.

scientific article

A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/587893
P8608Fatcat IDrelease_yndw2vuusnd5nklzktqi6y67mi
P698PubMed publication ID18433335
P5875ResearchGate publication ID5420237

P50authorFrançoise Perdreau-RemingtonQ115868118
Simon O'HanlonQ29998772
Mark EnrightQ41847851
Jonathan C ThomasQ79411305
Henry F ChambersQ89407615
Binh An DiepQ115867976
P2093author name stringPeter Jensen
Brian S Schwartz
Li Basuino
Christopher J Graber
Richard Jacobs
Catherine Liu
Shelley Gordon
Michael Karr
Gifford Leoung
Helen Gunthorpe
James S Rumack
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectSan FranciscoQ62
epidemiologyQ133805
Staphylococcus aureusQ188121
methicillin-resistant Staphylococcus aureusQ595158
P304page(s)1637-1646
P577publication date2008-06-01
P1433published inClinical Infectious DiseasesQ5133764
P1476titleA population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005
P478volume46

Reverse relations

cites work (P2860)
Q35178848A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001-2010.
Q38420470A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail.
Q37868663A retrospective review of streptococcal infections in pediatric atopic dermatitis
Q41042665Absence of the mecA Gene in Methicillin Resistant Staphylococcus aureus Isolated from Different Clinical Specimens in Shendi City, Sudan
Q99548876Algae Polyphenolic Compounds and Modern Antibacterial Strategies: Current Achievements and Immediate Prospects
Q35379738Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach
Q33826253Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008
Q29616084Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America
Q30393422Basis of Virulence in Community-Associated Methicillin-ResistantStaphylococcus aureus
Q42220885Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study
Q42284810Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units
Q57716541Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005–2008
Q34489712Changing epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines
Q91915202Characteristics and risk factors of hospital acquired - Methicillin-resistant Staphylococcus aureus (HA-MRSA) infection of pediatric patients in a tertiary care hospital in Riyadh, Saudi Arabia
Q34157657Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children
Q46264770Clonality of Staphylococcus aureus colonization over time in attendees of a camp for children with chronic dermatoses
Q35736907Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?
Q38023627Community-associated methicillin-resistant Staphylococcus aureus and athletes
Q33792021Community-associated methicillin-resistant Staphylococcus aureus case studies
Q24614464Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic
Q36438720Community-associated meticillin-resistant Staphylococcus aureus
Q37465197Community-associated meticillin-resistant Staphylococcus aureus infections: epidemiology, recognition and management
Q45979789Comparative Genomics of Community-Associated Methicillin-Resistant Staphylococcus aureus Shows the Emergence of Clone ST8-USA300 in Geneva, Switzerland.
Q37225887Comparative Molecular Characteristics of Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Isolates From Adult Patients in Northern Taiwan
Q36853965Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus
Q34802617Current status of Staphylococcus aureus infection in a central teaching hospital in Shanghai, China
Q27015365Development of a vaccine against Staphylococcus aureus
Q89522471Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies
Q35807224Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California
Q36256138Discriminatory Indices of Typing Methods for Epidemiologic Analysis of Contemporary Staphylococcus aureus Strains
Q43977829Distribution of methicillin-resistant Staphylococcus aureus in a low-prevalence area
Q34700948Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California
Q37470451Diversity of methicillin-resistant Staphylococcus aureus strains isolated from residents of 26 nursing homes in Orange County, California
Q47396324Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).
Q36882495Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.
Q34531313Emergence of community-associated methicillin-resistant Staphylococcus aureus carriage in children in Cambodia
Q38599573Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization
Q34542185Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis
Q37387212Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals
Q37392917Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.
Q34343212Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus
Q38587293Evolving Epidemiology of Staphylococcus aureus Bacteremia
Q50221694Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells
Q42110580Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus.
Q36337074Global fluoroquinolone resistance epidemiology and implictions for clinical use.
Q35214682High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania
Q48226214In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
Q37190797In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Q28384260Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study
Q35979644Internet queries and methicillin-resistant Staphylococcus aureus surveillance
Q37800939Invasive community-associated MRSA infections: epidemiology and antimicrobial management
Q33703737Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates
Q28087717Livestock-Associated MRSA: The Impact on Humans
Q36565462Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall
Q40175113Mechanisms of pyocyanin toxicity and genetic determinants of resistance in Staphylococcus aureus
Q37810406Methicillin-ResistantStaphylococcus aureus: A Community Health Threat
Q37690736Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007.
Q37410587Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate staphylococcus aureus isolates from patients with septic arthritis
Q34001847Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals.
Q33594673Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis
Q34056748Molecular pathogenesis of Staphylococcus aureus infection
Q37374776Molecular surveillance and population structure analysis of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in high-risk wards
Q36505512Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.
Q27024628Neutrophils in innate host defense against Staphylococcus aureus infections
Q37658260Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic
Q33430160Pediatricians' perspectives on the impact of MRSA in primary care: a qualitative study
Q36562825Polymorphisms in HLA Class II Genes Are Associated With Susceptibility to Staphylococcus aureus Infection in a White Population
Q37156850Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers
Q57815323Prevalence and risk factors of community-associated methicillin-resistant carriage in Asia-Pacific region from 2000 to 2016: a systematic review and meta-analysis
Q26829702Progress toward a Staphylococcus aureus vaccine
Q36915928Prolonged colonization with the methicillin-resistant Staphylococcus aureus strain USA300 among residents of extended care facilities.
Q92276235Proteomics and Docking Study Targeting Penicillin-Binding Protein and Penicillin-Binding Protein2a of Methicillin-Resistant Staphylococcus aureus Strain SO-1977 Isolated from Sudan
Q40120838Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting
Q36916829Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta
Q37328515Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.
Q37998398Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example
Q45968817Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring.
Q39901128Significantly larger numbers of methicillin-resistant Staphylococcus aureus bacteria are recovered from polymicrobial respiratory and wound sites by use of chromogenic primary media than by use of conventional culture
Q34097990Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost.
Q30998878Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management
Q34438470Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi
Q91749993Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective study
Q35689101Spontaneous staphylococcal cassette chromosome mec element excision in Staphylococcus aureus nasal carriers
Q31057448Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils
Q38151142Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage
Q33604961Staphylococcus aureus - antimicrobial resistance and the immunocompromised child
Q35193427Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008
Q34478074Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.
Q37203727The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300.
Q30525482The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).
Q54190309The mechanism of antibacterial activity of phlorofucofuroeckol-A against methicillin-resistant Staphylococcus aureus.
Q37090265The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogens
Q33523664To screen or not to screen for methicillin-resistant Staphylococcus aureus
Q36023013Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization
Q44942892Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients
Q33961776Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States
Q95355781Vancomycin Resistance in Staphylococcus aureus
Q42153532Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates
Q57614217Variability of SCCmec in the Zurich area
Q30397807Wall teichoic acids mediate increased virulence in Staphylococcus aureus
Q33854398Waves of resistance: Staphylococcus aureus in the antibiotic era.
Q57921961What has molecular epidemiology ever done for wildlife disease research? Past contributions and future directions

Search more.